Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: Qatar experience.
Mohamad Mahmood AlkadEssa A AbuhelaiqaMostafa F ElshirbenyAhmed F HamdiOmar M FituriMuhammad AsimSaad R AlkaabiMoutaz F DerbalaMona E JarmanAdel M AshourAwais NaumanYousuf K Al MaslamaniAdeel A ButtHassan A Al-MalkiPublished in: Immunity, inflammation and disease (2020)
HCV infection was successfully eradicated by DAA therapy in kidney transplant recipients, with a 100% SVR rate. Moreover, DAA therapy was well-tolerated, and kidney function remained stable without an increased risk of rejection. These results are expected to drive the eradication of hepatitis C from the entire country.